- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT01497730
10003 PRO Current Products (10003)
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
This post-marketing investigation will evaluate the functional knee performance of Subjects who have undergone primary total knee arthroplasty (TKA). Data from Subjects who receive one of four contemporary knee configurations from different manufacturers will be pooled to establish a contemporary dataset.
The primary objective of this study is to evaluate the functional performance as measured by the activities of daily living (ADL) sub-score of the Knee Osteoarthritis Outcomes Score (KOOS) patient-reported outcome (PRO) questionnaire of primary TKA at minimum one year post-operation. This will be carried out for all four implant configurations. The final endpoint is a 2-year evaluation.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
The study is designed as a prospective, single arm stratified, multi-center investigation.
Approximately 20 study sites, worldwide, will enroll 840 patients (840 knees). Each study site is expected to enroll approximately 42 patients (42 knees). Cohort reallocation is permitted. There will be no control group. Eight hundred forty (840) Subjects will be stratified into 4 subgroups of 210: fixed bearing cruciate retaining (FB CR), fixed bearing posterior stabilized (FB PS), rotating platform cruciate retaining (RP CR), and rotating platform posterior stabilized (RP PS).
Treatment assignment in this study is not randomized. Each site will only enroll patients in one of the four knee configuration sub-groups most commonly used as their standard of care.
Typ studiów
Zapisy (Rzeczywisty)
Kontakty i lokalizacje
Lokalizacje studiów
-
-
New South Wales
-
Hornsby, New South Wales, Australia, 2077
- Hornsby Ku-Ring-Gai Hospital
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Wakefield Orthopedic Clinic
-
-
Western Australia
-
Crawley, Western Australia, Australia, 6009
- Freemantle Hospital
-
Perth, Western Australia, Australia, 6000
- Royal Perth Hospital
-
-
-
-
-
Auckland, Nowa Zelandia
- Ascot Hospital
-
-
-
-
California
-
Orange, California, Stany Zjednoczone, 92868
- Orthopaedic Specialty Institute
-
San Diego, California, Stany Zjednoczone, 92103
- UCSD Medical Center
-
-
Colorado
-
Fort Collins, Colorado, Stany Zjednoczone, 80525
- Orthopaedic Center of the Rockies
-
-
Florida
-
Jacksonville, Florida, Stany Zjednoczone, 32205
- Heekin Institute for Orthopedic Research
-
-
Kentucky
-
Louisville, Kentucky, Stany Zjednoczone, 40215
- The Arthroplasty Foundation
-
-
Louisiana
-
New Orleans, Louisiana, Stany Zjednoczone, 70112
- Tulane University Hospital and Clinic
-
-
Nevada
-
Las Vegas, Nevada, Stany Zjednoczone, 89128
- Hip and Knee Research of Nevada
-
-
New Hampshire
-
Lebanon, New Hampshire, Stany Zjednoczone, 03756
- Dartmouth Medical School/Dartmouth-Hitchcock Medical Center
-
-
Ohio
-
Columbus, Ohio, Stany Zjednoczone, 43213
- Cardinal Orthopaedic Institute
-
-
Virginia
-
Alexandria, Virginia, Stany Zjednoczone, 22307-9804
- Anderson Orthopaedic Research Institute
-
-
Washington
-
Seattle, Washington, Stany Zjednoczone, 98122-5330
- Swedish Orthopedic Institute
-
-
-
-
-
Harlow, Zjednoczone Królestwo, CM20 1QX
- Princess Alexandra Hospital
-
Llandough, Zjednoczone Królestwo, CF64 2XX
- University Hospital Llandough
-
Middlesborough, Zjednoczone Królestwo, TS4 3BW
- James Cook University Hospital
-
York, Zjednoczone Królestwo, YO30 5RA
- Clifton Park NHS Treatment Centre
-
-
Fife
-
Dunfermline, Fife, Zjednoczone Królestwo, KY12 OSU
- Queen Margaret Hospital
-
-
Surrey
-
Guildford, Surrey, Zjednoczone Królestwo, GU2 7XX
- The Royal Surrey County Hospital
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria:
- Subject is male or female and between the ages of 22 and 80 years, inclusive.
- Subject was diagnosed with NIDJD.
- Subject is a suitable candidate for cemented primary TKA using the devices described in this CIP with either a resurfaced or non-resurfaced patellae.
- Subject's TKA device was one of the total knee prostheses described under Interventions.
- Subject is currently not bedridden.
- Subject has given voluntary, written informed consent to participate in this clinical investigation, is willing and able to perform all study procedures and follow-up visits and has authorized the transfer of his/her information to DePuy.
- Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and co-operate with investigational procedures.
- Subject must be comfortable with speaking, reading, and understanding questions and providing responses in English.
- The devices specified in this CIP were implanted.
Exclusion Criteria:
- The Subject is a woman who is pregnant or lactating.
- Contralateral knee has already been enrolled in this study.
- Subject had a contralateral amputation.
- Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee.
- Subject is currently experiencing radicular pain from the spine.
- Subject has participated in an IDE/IND clinical investigation with an investigational product in the last three months.
- Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
- Subject is a known drug or alcohol abuser or has a psychological disorder that could affect their ability to complete patient reported questionnaires.
- Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication.
- Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease).
- Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.).
- Subject is not comfortable with speaking, reading, and understanding questions and providing responses in an available translated language for the PROs in the CIP.
- Subject has a medical condition with less than 2 years of life expectancy.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
Interwencja / Leczenie |
|---|---|
|
CR FB
Subjects receiving a Cruciate Retaining Fixed Bearing implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
PS FB
Subjects Receiving a Posterior Stabilized Fixed Bearing implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
CR RP
Subjects receiving a Cruciate Retaining Rotating Platform implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
PS RP
Subjects receiving a Posterior Stabilized Rotating Platform implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Knee injury and Osteoarthritis Outcome Score (KOOS) activities of daily living (ADL) sub-score
Ramy czasowe: up to one year
|
The primary endpoint will be measuerd before surgery and out to a minimum of 1 year after surgery.
The KOOS is a patient self-administered questionnaire that consists of 42 questions.
The KOOS consists of 5 subscales; pain, other symptoms, activities of daily living (ADL), sport and recreational function and knee-related quality of life.
Each question has 5 Likert-like response options.
A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
|
up to one year
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Evaluate the psychometric properties of PKIP
Ramy czasowe: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
The Pre and Post-Surgical Patient's Knee Implant Performance (PKIP) questionnaire is a patient self-administered questionnaire that consists of 25 questions relating to the patient's awareness of their knee.
Questions include the patient's self-confidence about the current status of their knee performance, stability, and overall satisfaction.
Each question has a 5, 6 or 10 Likert- like response option.
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
Evaluate the longitudinal functional performance of primary TKA
Ramy czasowe: < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
< 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate Incidence of Anterior Knee Pain
Ramy czasowe: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate incidence of asymptomatic and symptomatic crepitus
Ramy czasowe: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate patients functional performance for PS knees, CR knees, FB knees, and RP knees
Ramy czasowe: < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
< 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Współpracownicy i badacze
Sponsor
Śledczy
- Dyrektor Studium: Ahmad S. Ismail, MS, CCRP, DePuy Orthopaedics
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 10003
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Total Knee Replacement
-
Zimmer BiometZakończonyReumatyzm | Ból kolana | Przewlekła choroba zwyrodnieniowa stawów | Jałowa martwica kłykcia kości udowej | Umiarkowane szpotawość, koślawość lub deformacje zgięciaBelgia, Szwajcaria, Niemcy, Izrael, Włochy
-
Zimmer BiometZakończonyReumatyzm | Ból kolana | Przewlekła choroba zwyrodnieniowa stawów | Jałowa martwica kłykcia kości udowej | Umiarkowane szpotawość, koślawość lub deformacje zgięciaStany Zjednoczone
-
Zimmer BiometZakończonyReumatyzm | Ból kolana | Przewlekła choroba zwyrodnieniowa stawów | Umiarkowane szpotawość, koślawość lub deformacje zgięcia | Jałowa martwica kłykcia kości udowejKanada
-
Smith & Nephew, Inc.WycofaneArtroplastyka | Kolano | ZastąpienieSingapur, Chiny, Indie
-
ExactechRekrutacyjnyArtroplastyka stawu kolanowego, całkowitaStany Zjednoczone
-
Stryker OrthopaedicsZakończony
-
Smith & Nephew, Inc.ZakończonyCałkowita alloplastyka stawu kolanowegoStany Zjednoczone, Belgia, Szwajcaria
-
Aesculap Implant SystemsZakończonyZwyrodnieniowa choroba dyskuStany Zjednoczone
-
Johnson & Johnson Medical (Suzhou) Ltd.ZakończonyBadanie kliniczne systemu kolanowego w pierwotnej całkowitej alloplastyce stawu kolanowego w ChinachZapalenie stawów, reumatoidalne | Zapalenie kości i stawów | Pourazowe; ArtrozaChiny
-
Zimmer BiometZakończonyChoroba stawówZjednoczone Królestwo